Tectonic Therapeutic | AVRO - Pre Tax Profit


Tectonic Therapeutic reported $-18.97M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
Alnylam Pharmaceuticals USD 177.81M 43.85M Jun/2026
Celltrion KRW 11.84B 1.34B Mar/2026
Cspc Pharmaceutical CNY 505.59M 706M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Divis Laboratories Ltd INR 11.8B 2.17B Jun/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
Ionis Pharmaceuticals USD -114M 21M Jun/2026
Kangmei Pharma CNY -14.01M 16.08M Mar/2026
Karyopharm Therapeutics USD -39.9M 9.01M Dec/2025
Knight Therapeutics CAD -1.92M 13.69M Sep/2025
Laboratorios Farma EUR 26.78M 94.77M Jun/2025
MacroGenics USD -36.77M 21.84M Mar/2026
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Organigram Holdings CAD -921K 40.8M Mar/2026
Pfizer USD 5.18B 6.82B Mar/2026
Pharma Mar EUR -993K 2.59M Jun/2026
Qiagen NV USD 85.83M 23.34M Mar/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sanofi EUR 837M 1.17B Jun/2026
Sarepta Therapeutics USD 343.17M 750.85M Mar/2026
Sartorius EUR 127M 30.8M Jun/2026
Takeda JPY 162.72B 215.2B Jun/2026
Tilray USD -39.96M 39.19M Sep/2025
Zealand Pharma A/S -394M 12.5M Mar/2026
Zz Pientze Pharmaceu CNY 876.07M 352.96M Mar/2026